ReviewGenes2019
Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine.
Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Narratives and tensions in the ethics of human proteomics literature: a scoping review.BMC medical ethics · 2026Pooled it
- Ethical Principles, Constraints and Opportunities in Clinical Proteomics.Molecular & cellular proteomics : MCP · 2021Pooled it
- Review
- Prior knowledge informs graph neural networks to improve phenotype prediction from proteomics.medRxiv : the preprint server for health sciences · 2025Article
- A roadmap for navigating child health research data sharing across Canada and beyond - building on UCAN CAN-DU.Pediatric rheumatology online journal · 2025Article
- Current cutting-edge omics techniques on musculoskeletal tissues and diseases.Bone research · 2025Review
- Cohort profile: The Belgian I AM frontier prospective cohort study for comprehensive health outcome exploration.PloS one · 2025Article
- Assessing Privacy Vulnerabilities in Genetic Data Sets: Scoping Review.JMIR bioinformatics and biotechnology · 2024Article
- Systematic identification of the role of gut microbiota in mental disorders: a TwinsUK cohort study.Scientific reports · 2024Article
- Deep learning-driven fragment ion series classification enables highly precise and sensitive de novo peptide sequencing.Nature communications · 2024Article
- Large scale proteomic studies create novel privacy considerations.Scientific reports · 2023Article
- Advances in single-molecule junctions as tools for chemical and biochemical analysis.Nature chemistry · 2023Review
- Article
- Associations between the Willingness to Donate Samples to Biobanks and Selected Psychological Variables.International journal of environmental research and public health · 2022Article
- Identifying individuals using proteomics: are we there yet?Frontiers in molecular biosciences · 2022Review
- Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review.Frontiers in physiology · 2021Review
- Recommendations for Creating Codes of Conduct for Processing Personal Data in Biobanking Based on the GDPR art.40.Frontiers in genetics · 2021Article
- Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future.Molecular & cellular proteomics : MCP · 2021Article
- Comprehensive Detection of Single Amino Acid Variants and Evaluation of Their Deleterious Potential in a PANC-1 Cell Line.Journal of proteome research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing availability of high throughput proteomics data provides us with opportunities as well as posing new ethical challenges regarding data privacy and re-identifiability of participants. Moreover, the fact that proteomics represents a level between the genotype and the phenotype further exacerbates the situation, introducing dilemmas related to publicly available data, anonymization, ownership of information and incidental findings. In this paper, we try to differentiate proteomics from genomics data and cover the ethical challenges related to proteomics data sharing. Finally, we give an overview of the proposed solutions and the outlook for future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.